INSULIN Act
- Sep 28Shaheen called for Senate floor vote on bipartisan bill to cap monthly insulin costs at $35.
- Oct 2Shaheen highlighted editorial support for INSULIN Act capping monthly insulin costs at $35.
| Action type | Wk ofJul 5 | Wk ofJul 12 | Wk ofJul 19 | Wk ofJul 26 | Wk ofAug 26 | Wk ofAug 92 | Wk ofAug 164 | Wk ofAug 23 | Wk ofAug 309 | Wk ofSep 61 | Wk ofSep 135 | Wk ofSep 203 | Wk ofSep 277 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sent lettersTo agencies, companies, officials | 5 | |||||||||||||
| HearingsHeld, testified or questioned | 1 | |||||||||||||
| CriticizedA policy, decision or person | 1 | |||||||||||||
| PraisedCredit for a decision or person | 5 | |||||||||||||
| Visits and eventsTours, town halls, site visits | 2 | |||||||||||||
| Filed or pushed billsNew, reintroduced or passed | 22 | |||||||||||||
| Other | 1 |
+15 more with fewer actions
Led letter from 71 members urging agencies to allow continued prescription drug imports from Canada.
Highlighted editorial support for INSULIN Act capping monthly insulin costs at $35.
Introduced bipartisan bill to expand access to lower-cost biosimilar drugs.
Introduced bipartisan bill to establish 10,000 secure opioid disposal receptacles nationwide.
Introduced bipartisan bill to improve pharmacy reimbursement data and reduce patient out-of-pocket costs.
Called for Senate floor vote on bipartisan bill to cap monthly insulin costs at $35.
Questioned FDA nominee on mifepristone safety, medication abortion, and food safety failures.
Introduced legislation to protect Medicare beneficiaries from losing prescription drug coverage due to surprise premium payment failures.
Commended Trump administration for extending Most Favored Nation drug pricing to all state Medicaid programs.
Introduced bipartisan bill to increase transparency in prescription drug pricing.
Introduced bipartisan bill to increase transparency in prescription drug pricing.
Sent letter to HHS and CMS recommending Medicare incentives for American-made essential medicines.
Introduced bipartisan bill to cap insulin costs at $35 or 25% of list price monthly.
Introduced bipartisan bill to cap insulin costs at $35 monthly for all Americans.
Praised House introduction of bipartisan bill capping monthly insulin out-of-pocket costs at $35.
Led bipartisan effort to cap insulin out-of-pocket costs at $35 monthly for private insurance.
Introduced two bills to lower prescription drug prices and protect hospital drug discounts.
Highlighted bipartisan bill capping monthly insulin costs at $35 for insured and uninsured Americans.
Met with pharmacists to discuss pharmacy benefit manager reform and prescription drug costs.
Introduced bill to redirect Medicare Part D premium relief to seniors instead of insurance companies.
Joined 50 House colleagues calling on CMS to reverse Medicare drug cost demonstration termination.
Joined pharmacists to call for pharmacy benefit manager reforms to lower drug prices.
Celebrated four years of Medicare drug price negotiation under the Inflation Reduction Act.
Praised largest 12-month decline in prescription drug prices since 1963 from Medicare negotiations.
Introduced bipartisan bill to reform 340B Drug Pricing Program for vulnerable patient access.
Introduced bipartisan legislation to strengthen and reform the 340B drug program.
Led 50 members demanding Trump administration reverse Medicare Part D drug program termination.
Criticized Trump administration for ending Medicare subsidies that lower prescription drug costs for seniors.
Introduced bill to combat foreign pharmaceutical price controls and hold trading partners accountable.
Introduced bipartisan bill to reform and strengthen the 340B drug discount program.
Summaries, action types, amounts and positions are read from each press release by AI and can be wrong. Joint releases (same day, same action, matching title or amount) count once. How it works